Fundz

Linnaeus Therapeutics, Inc. reported raising $5.82 Million in an initial SEC Form D filing

PRIVATESep 07, 2018

Amount Raised

$5.82 Million

$5.82 Million sold, per SEC Form D (first sale Sep 7, 2018)

Round Type

Venture

HaddonfieldBiotechnologyresearch

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Linnaeus Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Qpex Biopharma raised $22M on October 16, 2018.
  • BNB Plus raised $1.6M (Seed) on September 4, 2018.
  • Kernal Biologics raised $500K on August 15, 2018.
  • THERALASE TECHNOLOGIES INC /FI raised $160K (Pre-Seed) on October 19, 2018.
  • PHOENIX BIOTECHNOLOGY INC raised $879K (Seed) on October 18, 2018.
  • Kemin Industries raised $100M on October 18, 2018.

Who to call at Linnaeus Therapeutics, and when

A new round usually means Linnaeus Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Linnaeus Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Linnaeus Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Linnaeus Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Linnaeus Therapeutics

Location

30 WASHINGTON AVENUE, SUITE F

Haddonfield, New Jersey, United States

About

Linnaeus Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that target G protein-coupled receptors. The company was formed and launched in partnership with the UPstart incubator at the University of Pennsylvania’s Penn Center for Innovation (PCI).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Linnaeus Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsPatrick M., Executive Officer, Director hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Linnaeus Therapeutics's next move

See what Strategic adds

Linnaeus Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.